Want to join the conversation?
$ABBV said Stemcentrx has a broad development program for Rova-T currently underway. The confirmatory third-line trial which is called Trinity began in January and is expected to complete enrollment by the end of 2016 with commercialization expected in 2018. Stemcentrx is also moving into front-line, small cell lung cancer with Rova-T.
Planned to give Apple AirPods as a Christmas present to my beloved one. Looks like I need backup plans as $AAPL is delaying the release..!!
When you fall hard, I think you stay there for a long time.. I am looking at you $FTNT! After it released the earnings, the share price slipped and is staying around $30 for a long time.
$FOXA just entered into a preliminary deal with Sky plc under which it will acquire all shares, or should I say remaining shares for a total value of $23 billion. The sleeping fox catches no poultry, but this fox just caught something that’s a lot bigger than poultry.